![John S. Pallies](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John S. Pallies
Nessuna posizione attualmente
Profilo
Mr. John S.
Pallies is Chief Financial Officer, Secretary & Treasurer at Syndax Pharmaceuticals, Inc.
Mr. Pallies was previously employed as Controller & Finance Director by Cerimon Pharmaceuticals, Inc., a Director-Financial Operations by Akamai Technologies, Inc., and Management Consultant by Arthur Andersen LLP.
He received his undergraduate degree from Boston College and an MBA from the Wallace E Carroll School of Management.
Precedenti posizioni note di John S. Pallies
Società | Posizione | Fine |
---|---|---|
SYNDAX PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 20/01/2016 |
Arthur Andersen LLP
![]() Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Corporate Officer/Principal | - |
AKAMAI TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Direttore Finanziario/CFO | - |
Formazione di John S. Pallies
Boston College | Undergraduate Degree |
Wallace E Carroll School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
AKAMAI TECHNOLOGIES, INC. | Technology Services |
Aziende private | 2 |
---|---|
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Health Technology |
Arthur Andersen LLP
![]() Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
- Borsa valori
- Insiders
- John S. Pallies